tiprankstipranks
Protagonist Therapeutics (PTGX)
NASDAQ:PTGX

Protagonist Therapeutics (PTGX) Stock Investors

561 Followers
Based on 723,149 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold PTGX
On average, investors allocate 3.61% of their portfolios to PTGX
The average holding size of this company in investors' portfolios.

Investor Sentiment

Negative
Sector
Average
Stock Sentiment
Sold
Bought
Based on the activity of 723,149 investors in the recent quarter
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding PTGX

1.2%
Last 7
Days
2.5%
Last 30
Days
Percentages indicate the change in the number of portfolios holding PTGX, out of 723,149 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

PTGX Investor Activity

Investor Profile
Investor Action
Transaction Date
Portfolio Allocation
Execution Price
Follow
Opened
0.33%
$29.53
Based on the activity of 13,602 investors who made their portfolios public
The table shows changes in PTGX in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

PTGX Investors Also Bought

Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
DraftKings
7.22%
+0.86%
+1.66%
40.91B
Consumer Cyclical
Coherus Biosciences
2.69%
-0.54%
-3.68%
259.48M
Healthcare
ChargePoint Holdings
3.95%
-1.04%
-3.27%
727.37M
Consumer Cyclical
Merck & Company
4.04%
+0.19%
+0.58%
313.67B
Healthcare
Riot Platforms
4.98%
+0.99%
+6.18%
2.89B
Financial
Marathon Digital Holdings
5.70%
-0.56%
+7.09%
5.90B
Financial
Micron
5.59%
+10.90%
+26.10%
122.04B
Technology
Marvell
4.73%
+2.09%
+11.09%
57.62B
Technology
Trade Desk
4.72%
+0.67%
+1.32%
41.59B
Technology
ServiceNow
3.99%
+1.69%
+7.01%
158.70B
Technology
Based on the activity of 723,149 active portfolios
Open your Smart Portfolio

PTGX Investor Analysis

PTGX investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
13.1%
of PTGX holders
are under 35
Average Segment Performance
Average P/E Ratio56.24
Beta7.70
Dividend Yield5.72%
PTGX investors between 35–55

Between 35–55

0.0%
Last 30 days
Holdings Change
43.4%
of PTGX holders
are between 35–55
Average Segment Performance
Average P/E Ratio61.68
Beta11.71
Dividend Yield6.34%
PTGX investors over 55

Over 55

3.9%
Last 30 days
Holdings Change
43.4%
of PTGX holders
are over 55
Average Segment Performance
Average P/E Ratio53.31
Beta6.02
Dividend Yield6.03%
Overview of age group and performance of PTGX stock investors
See who invests in PTGX according to age group and performance.

FAQ

How many retail Investors hold PTGX?
<0.1% of TipRanks' retail investors hold PTGX in their portfolios.
    What is PTGX Investor Sentiment?
    PTGX’s Investor Sentiment is Negative.
      What percentage of retail investors changed their holding of PTGX in the last 7 days?
      ▲ 1.2% of TipRanks' retail investors changed their holding of PTGX in the last 7 days.
        What percentage of retail investors changed their holding of PTGX in the last 30 days?
        ▼ 2.5% of TipRanks' retail investors changed their holding of PTGX in the last 30 days.
          What is the average age of retail investors who hold PTGX?
          The average age of PTGX Holders is over 55.
            What other stocks have PTGX investors also bought?
            PTGX Investors also bought DKNG, CHRS, CHPT, MRK, RIOT, MARA, MU, MRVL, TTD, NOW.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              ABTAbbott Labs
              ATECAlphatec Holdings
              CORCencora
              AZNAstraZeneca
              NOTVInotiv
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis